For context on the broader regulatory picture in 2026, Peptide Therapy and Mainstream Medicine in 2026 is worth reading alongside this guide
This can guide initial dose timing, lifestyle expectations, and whether compounded semaglutide, tirzepatide, or a dual-peptide approach may align best with your metabolic phenotype
Why Deficiency Matters While severe deficiencies only affect up to 2 percent of the general population, subclinical deficiencies are more common
Advanced Peptide Therapies Going Beyond GLP-1 For patients who want a more comprehensive metabolic approach, or who want to enhance their results beyond what GLP-1 medications alone provide, we offer advanced peptide therapy protocols
If you had congestion beneath the surface, clogged pores, dormant breakouts waiting to happen, accumulated cellular debris, that faster turnover brings everything to the surface simultaneously